StockTipsArenaBeta

BUY Mankind Pharma Limited — Nilesh Jain, Centrum Broking

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Intraday)29 Sept 2026, 1:11 pm ISTvia Zee Business (Live)

Entry₹2,530Inferred
Target₹2,580
Total upside +1.98% (call closed)
Stop loss₹2,480-1.98% risk
At expiry₹2,548.429 Sept 2026, 3:05 pm
Expired+0.73%
Follow Nilesh Jain for new calls(10% target hit, 51 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 29 Sept 2026
2 supporting2 opposing
Supports the BUY call (2)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·24 Sept · 5d ago

Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend

NewsLivemint·22 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

Mankind Pharma auditor resigns as subsidiary Bharat Serums enters liquidation

NewsGoogle News·28 Sept · today

(opens in new tab)

Mankind Pharma's subsidiary Bharat Serums and Vaccines sees auditor resignation amid liquidation

NewsGoogle News·28 Sept · today

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from Nilesh Jain, Centrum Broking

Every call and its outcome